Home›People›Mostafa Ronaghi
Mostafa Ronaghi

Mostafa Ronaghi

Director at Summit Therapeutics. Also a cofounder, executive board member at Cellanome and a director at Tachin.AI and Clear Labs.

DirectorPublic companyRoles at 4 startups
Updated Nov 10, 2026·Latest SEC filing Jun 22, 2026·Suggest an edit

About Mostafa Ronaghi

Mostafa Ronaghi is a director at Summit Therapeutics.

Form D filings name Mostafa Ronaghi as a cofounder, executive board member at Cellanome and a director at Tachin.AI, Clear Labs and 1health.io Inc...

Mostafa Ronaghi reports to the SEC as a director or officer of 4 public companies, including Seer (SEER), Senti Biosciences (SNTI) and Illumina (ILMN).

Mostafa Ronaghi first appears on SEC filings in 2008.

Experience

This experience comes from Mostafa Ronaghi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Mostafa Ronaghi in the role, so the role may have started earlier or lasted longer.

Summit Therapeutics Inc. Current
Member Board of Directors
2024 – Present · Public company (SMMT)
Cellanome, Inc. Current
Cofounder, Executive Board Member
Executive Board Member and Co-founder (2021 – Present)
2021 – Present · Foster City, CA
Cellanome makes a live-cell analysis platform for biological researchers.
1health.io Inc.. Current
Director
2020 – Present · San Francisco, CA
Clear Labs, Inc. Current
Director
2014 – Present · San Carlos, CA
Tachin.AI Corp
Director
2025 · San Francisco, CA
Seer.bio
Board Member
2021 – 2024
Seer, Inc.
Director
2021 – 2023 · Public company (SEER)
Dynamics Special Purpose Corp.
Chief Executive Officer
2021 – 2022
Senti Biosciences, Inc.
Chief Executive Officer and director
2021 · Public company (SNTI)
GRAIL, Inc.
Co-Founder and Board of Director
2016 – 2021
Illumina, Inc.
SVP, Entrepreneurial Devlopmt
SVP, Entrepreneurial Development (2008 – 2021)
2008 – 2021 · Public company (ILMN)
Aurora Algae, Inc
Board of Director
2007 – 2015
IntegenX. Inc.
Board of Director & SAB member
2006 – 2013
NextBio (acquired by illumina)
Founder and Board of Director
2004 – 2013
Avantome (Acquired by Illumina in 2008)
Founder
2008
Stanford Univ
Principal Investigator
1999 – 2008
ParAllele BioScience (acquired by Affymetrix in 2005)
Founder
2001 – 2005
ParAllele Biosciences
Board of Director and Scientific Advisory Board
2001 – 2005
Pyrosequencing (Biotage since 2003)
Founder (1997 – 2000)
Board of Director (1997 – 1999)
1997 – 2000
Royal Intitute of Technology / Dept. of Biotechnology
alumni
1994 – 1999
KTH
graduate student
1994 – 1998

Key Colleagues at Startups

The people Mostafa Ronaghi works with at each company, as listed on that company's latest Form D.

Cellanome, Inc. · Form D, Jun 22, 2026
MK
SP
Sandesh Patnam
Board Member
Omead Ostadan
Omead Ostadan
CEO, Board Member
Rowan Chapman
Rowan Chapman
Board Member
Jay Flatley
Jay Flatley
Chairman
Tachin.AI Corp · Form D, Feb 28, 2025
RM
Reza Malek
Director
NH
Neil Hunt
Director
MM
Mehdi Maghsoodnia
Chief Executive Officer and director
SC
Clear Labs, Inc. · Form D, Dec 30, 2024
GY
Greg Yap
Director
Gaurav Garg
Gaurav Garg
Director
SA
Sasan Amini
Executive officer and director
Ming Fang
Ming Fang
Director
RK
Ramin Khaksar
Executive officer
EF
Edward Fan
Chief Financial Officer
1health.io Inc.. · Form D, Jul 25, 2023
RM
Reza Malek
Director
NH
Neil Hunt
Director
MM
Mehdi Maghsoodnia
President and director

Sources

  1. SECCellanome, Inc. Form D, filed Jun 22, 2026
  2. SECTachin.AI Corp Form D, filed Feb 28, 2025
  3. SECClear Labs, Inc. Form D, filed Dec 30, 2024
  4. SEC1health.io Inc.. Form D, filed Jul 25, 2023
  5. SECForms 3, 4 and 5 filed by Mostafa Ronaghi (SEC filer 1441876)